Information For DPL XXXVI
The American Society for Pharmacy Law (ASPL) is an organization of attorneys, pharmacists, pharmacist-attorneys and students of pharmacy or law who are interested in the law as it applies to pharmacy, pharmacists, wholesalers, manufacturers, state and federal government and other interested parties.

ASPL is a non-profit which encourages diversity & inclusion with the Society, regardless of differing backgrounds, perspectives, experiences, orientations, origins, and practice settings. The Society embraces participation and diversity as it leads to advancing our purpose: 

  • Furthering knowledge in the law related to pharmacists, pharmacies, the provision of pharmaceutical care, the manufacturing and distribution of drugs, and other food, drug, and medical device policy issues;
  • Communicating accurate legal educational information; and
  • Providing educational opportunities for pharmacists, attorneys, and others who are interested in pharmacy law

Latest News

September 30, 2025

District Court Upholds Maine 340B Law in Loss for Novartis and AbbVie

The US District Court for the District of Maine denied Novartis and AbbVie their bid to block a 340B law in the state. The law, the Maine Protect Health Care for Rural and Underserved Communities Act, allows hospitals to use 340B contract pharmacies. The manufacturers had argued that 340B federal law preempted Maine’s law. "The Court discerns nothing in 340B to suggest that Congress intended to limit the number of patients for whom covered entities may prescribe drugs at the discounted rate," U.S. Magistrate Judge John Nivison wrote.

[Order on Motions for Preliminary Junction. AbbVie Inc v Frey, U.S. D.C. Dist. ME, No. 1:25-cv-00416, Sept 23 2025. Novartis, Abbvie lose bid to block Maine law on federal drug discount program. Reuters 23 Sept 2025.]